Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.
News Menu



Mon, Mar 25th, 2019
Sydys Corporation Announces Filing of Form 15 to Deregister its Common Stock

NEW YORK , March 25, 2019 /PRNewswire/ -- Sydys Corporation (OTCPK: SYYC, the "Company"), globally active biotechnology company developing immuno-oncology products, today announced that on March...

SYYC : 0.2500 (-54.55%)
Neptune Receives Judgment On Claims By Former Chief Executive Officer

LAVAL, QC , March 25, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Corporation") (NASDAQ:  NEPT ) (TSX: NEPT) , announced that it has received a judgment from...

NEPT : 3.03 (+1.68%)
NEPT.TO : 4.04 (+0.75%)
Aquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference

WARREN, N.J. , March 25, 2019 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve...

AQST : 6.16 (-0.96%)
Cesca Therapeutics Announces Fiscal 2018 Year End Financial Results And Provides Corporate Update

RANCHO CORDOVA, Calif. , March 25, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and point-of-care, autologous cell therapies for regenerative...

KOOL : 0.30 (-3.23%)
Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Top-Line Results from the Phase 3 ALLEVIATE Trial in Allergic Conjunctivitis

LEXINGTON, Mass. , March 25, 2019 /PRNewswire/ -- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines...

ALDX : 7.14 (-4.16%)
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2019 Results: May 7, 2019

BRAINTREE, Mass. , March 25, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and full fiscal year 2019 financial results at...

HAE : 85.38 (+1.02%)
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at Endocrine Society Meeting (ENDO) 2019

PALO ALTO, Calif. , March 25, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare...

EIGR : 13.50 (-2.88%)
Guerbet Announces Transition from Temporary Importation to Regular Supply for Lipiodol® (ethiodized oil) Injection; also introduces new glass vial container

PRINCETON, N.J. , March 25, 2019 /PRNewswire/ -- Guerbet LLC USA , the U.S. affiliate of the global specialist in contrast media products and solutions for diagnostic and interventional imaging,...

GBT : 50.89 (+2.79%)
Settlement Reached Resolving Xarelto Multidistrict Litigation Claims

NEW ORLEANS , March 25, 2019 /PRNewswire/ -- The makers of the popular blood thinner Xarelto® have reached a $775 million settlement to resolve litigation filed by patients who suffered a bleeding...

JNJ : 136.61 (-0.22%)
BAYRY : 16.1800 (-2.74%)
What my DNA told me: Avoid fast food, eat vegetables

NEW YORK (AP) — Avoid fast food, eat vegetables and exercise. It sounds like generic health advice, but they're tips supposedly tailored to my DNA profile.

Encompass Health announces annual stockholder meeting date

BIRMINGHAM, Ala. , March 25, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) will hold its annual meeting of stockholders at 11:00 a.m. CDT , on Friday, May 3, 2019 . The meeting...

EHC : 59.61 (-1.05%)
Neogen launches coconut food allergen test kits

LANSING, Mich. , March 25, 2019 /PRNewswire/ -- Neogen's comprehensive line of tests to detect allergens in food products before they can reach consumers now includes simple and accurate tests for...

NEOG : 60.53 (+1.42%)
VolitionRx Limited to Present at Conferences in March & April 2019

ISNES, Belgium , March 25, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Executive Vice President, Investor Relations, Scott Powell ,...

VNRX : 3.08 (-0.32%)
Vireo Health Expands National Footprint with Entry into Arizona's Medical Cannabis Market

MINNEAPOLIS , March 25, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO), America's leading science-focused, multi-state cannabis company, today announced...

Curis Sells Portion of Erivedge Royalties to Oberland Capital for up to $135.7 million

LEXINGTON, Mass. , March 25, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced...

CRIS : 1.89 (+32.17%)
Theravance Biopharma Announces Ampreloxetine (TD-9855) Phase 2 Study Results Selected for Oral Presentation at 32nd European Neurology Congress

DUBLIN , March 25, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that data from the Company's Phase 2 clinical trial of...

TBPH : 22.95 (+0.57%)
Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials

MELBOURNE, Australia , March 25, 2019 /PRNewswire/ --  Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering...

PPCB : 0.0135 (+16.38%)
Varian Wins "Best After-Sales Service Award for Radiotherapy Products" in China Two Years In A Row

PALO ALTO, Calif. and BEIJING , March 25, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it again received the "Best After-Sales Service Award for Radiotherapy Products" in the 2018...

VAR : 138.71 (+0.09%)
Portage makes additional investment in Stimunity S.A, a Paris-based cancer immunotherapy company.

TORONTO , March 25, 2019 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (Canadian Securities Exchange: PBT.U, OTC Markets : PTGEF) , is pleased to announce that it has made...

PTGEF : 0.1090 (+14.74%)
New Long-term Outcomes Data Presented at St. Gallen International Breast Cancer Conference Reinforce TAILORx Treatment Paradigm and Standard of Care Use for Oncotype DX Breast Recurrence Score® Test

REDWOOD CITY, Calif. , March 25, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that new data presented at the 16th St. Gallen International Breast Cancer Conference...

GHDX : 70.68 (+1.89%)

Chart of the Day

Ameren Corp (AEE)

The Barchart Chart of the Day belongs to the electric utility company Ameren(AEE). I found the stock by using Barchart to sort the New All Time High list first by the most frequent number of new highs in the last month then I used the Flipchart feat...
Read More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar